An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI [magnetic resonance imaging] and Cognition in Patients With Moderate Dementia of the Alzheimer's Type

Trial Profile

An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI [magnetic resonance imaging] and Cognition in Patients With Moderate Dementia of the Alzheimer's Type

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jan 2010

At a glance

  • Drugs Memantine (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 04 Jan 2008 Status changed from in progress to completed.
    • 21 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top